RE: Positive Review2 Sep 2021 17:40
And previously (bit of catch up history for you) and something you might have missed coming next:
CELEBRATING INNOVATIVE COLLABORATION BETWEEN LABSKIN AND LEADING UNIVERSITIES
One major benefit of being based at a science park like York Biotech Campus is being around like-minded people who work in similar fields. The campus is an environment where there are many opportunities to share best practice and ideas, and ultimately drive forwards innovation and research and development (R&D).
Our tenants often collaborate with other businesses in their sectors, but another important piece of the puzzle is drawing on the knowledge and facilities that universities can offer. One tenant doing just this is Labskin, a leading skincare testing company that develops and grows an artificial human-like skin product.
Labskin work alongside several universities within the region and across the UK, including Sheffield Hallam University and the University of York. On its collaboration with universities, Dr Nicola Kingswell, Head of Laboratories at Labskin, said:
“The benefits of forging partnerships between universities and businesses in bioscience are very much two ways. Businesses often have a commercial focus and a route to market in terms of products, but the academic expertise, and in some cases, the facilities, that universities can supply, can provide outcomes that otherwise would not have come to fruition without a partnership.
“They are also extremely valuable in terms of nurturing future talent. For example, we can benefit from the knowledge of postgraduate students, whilst also providing the students with the opportunity to gain valuable sector experience through Knowledge Transfer Partnerships (KTPs). These are partly government funded programmes between businesses and universities, ranging from summer projects to one-year industry placements to research associate positions.
“Overall, through building relationships with universities, we’re all able to combine the latest insights in the academic field with what’s emerging in the commercial bioscience market, creating solutions to real-world problems at a pace and quality that wouldn’t be possible without this cooperation.”